Imagenetix, Inc. (IAGX) Research
Established in 1996 and headquartered in San Diego, California, Imagenetix, Inc. focuses on the creation, manufacturing, and distribution of distinctive, natural-ingredient nutritional supplements, as well as non-prescription topical creams and skincare solutions. Its flagship product, Celadrin, is a specialized formulation aimed at promoting joint well-being. The company also extends its business by licensing its proprietary technologies to third parties. Imagenetix reaches its customer base through a wide range of marketing avenues, encompassing direct and large-scale marketing enterprises, health and nutritional periodicals, medical and wellness professionals, and direct-response campaigns across radio and television.
Market snapshot
- Symbol
- IAGX
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $2.8K
- P/E ratio
- -0.13x
- 52-week range
- 0.0001-0.0001
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Peer companies
Open Imagenetix, Inc. (IAGX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.